Investigators of animal models of psychopathology have typically introduced experimental conditions so that an animal's behavior progressively deviates from a baseline of routine laboratory behavior toward a pattern which resembles human psychopathological behavior in some form of S, then R relation. The present experiments report consequential contingency procedures for bringing head-to-wall head-banging by an animal under experimental control and analysis. The first two experiments examined the establishment and maintenance by reinforcement of head-banging by pigeons. The final two experiments examined the occurrence of head-banging, under conditions of extinction and limited reinforcement, when an alternative behavior, i.e., key-pecking, was reinforced under a variety of reinforcement schedules. Extinguished and infrequently reinforced head-banging was found to recur under a variety of conditions including the reinforcement of the more "normal" alternative behavior. To the extent that human patterns are governed by similar functional relations, the data may be of relevance in the analysis of the maintenance, attenuation, and recurrence of human patterns designated as pathological. Further, the permanent elimination of a disturbing pattern may be difficult, and the recurrence of a disturbing pattern might properly be considered a likely and "normal" outcome of basic behavioral processes.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/s0005-7916(99)00003-8 | DOI Listing |
J Trauma Acute Care Surg
December 2024
From the Department of Surgery, University of Cincinnati, Cincinnati, Ohio.
Background: Red blood cell (RBC) aggregation can be initiated by calcium and tissue factor, which may independently contribute to microvascular and macrovascular thrombosis after injury and transfusion. Previous studies have demonstrated that increased blood storage duration may contribute to thrombotic events. The aims of this study were to first determine the effect of blood product components, age, and hematocrit (HCT) on the aggregability of RBCs, followed by measurement of RBC aggregability in two specific injury models including traumatic brain injury (TBI) and hemorrhagic shock.
View Article and Find Full Text PDFThe first clinical trial of zebrafish embryos acting as cancer "avatars" will start soon.
View Article and Find Full Text PDFPLoS One
January 2025
Department of Kidney Transplantation, Nephropathy Hospital, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaan'xi, China.
Increasing evidence suggests that dysbiosis of gut microbiota exacerbates chronic kidney disease (CKD) progression. Curcumin (CUR) has been reported to alleviate renal fibrosis in animal models of CKD. However, the relationship between CUR and gut microbiome in CKD remains unclear.
View Article and Find Full Text PDFPLoS One
January 2025
Medical Faculty, Department of Neurology, Otto von Guericke University, Magdeburg, Germany.
For the last 38 years, all neuroprotective agents for patients with ischemic stroke have failed in clinical trials. The innate immune system, particularly microglia, is a much-discussed target for neuroprotective agents. Promising results for neuroprotection by inhibition of integrins with drugs such as natalizumab in animal stroke models have not been translated into clinical practice.
View Article and Find Full Text PDFPLoS One
January 2025
Fujian Key Laboratory of Lung Stem Cells, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian, China.
Introduction: Pulmonary fibrosis (PF) is a chronic and irreversible interstitial lung disease characterized by a lack of effective therapies. Mesenchymal stem cells (MSCs) have garnered significant interest in the realm of lung regeneration due to their abundant availability, ease of isolation, and capacity for expansion. The objective of our study was to investigate the potential therapeutic role of umbilical cord-derived MSCs (UC-MSCs) in the management of PF, with a focus on the alterations in the gut microbiota and its metabolites during the use of UC-MSCs for the treatment of pulmonary fibrosis, as well as the possible mechanisms involved.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!